Orchestra BioMed Holdings, Inc. (OBIO) stock
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.25+1.10 (+17.89%)
Close on Nov 13, 2026Market cap $435.76MP/E –Yield –
Orchestra BioMed enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Orchestra BioMed's enterprise value was $251.27M on Nov 11, 2026, against $204.57M a year earlier. Over the last 5 years it ranged from -$63.19M to $348.98M, with a median of $112.32M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $251.27M | +81.4% |
| 2025 | Dec 31, 2025 | $138.51M | +63.2% |
| 2024 | Dec 31, 2024 | $84.85M | -61.1% |
| 2023 | Dec 29, 2023 | $217.85M | – |
| 2022 | Dec 30, 2022 | -$52.58M | -222.1% |
| 2021 | Dec 31, 2021 | $43.07M | – |
See a number that looks wrong?